Adding Pembrolizumab to Chemo Improves Survival in Endometrial Cancer

TUESDAY, April 4, 2023 -- The addition of pembrolizumab to paclitaxel plus carboplatin is associated with longer progression-free survival for patients with advanced or recurrent endometrial cancer, according to a study published online March 27 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news